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Background: Depression is currently considered the epidemic of the century. In recent decades, research has established that 
psychotherapy is globally effective for the treatment of depression; however, it remains open which psychotherapeutic treatment is 
most effective and, particularly, if its efficacy is maintained over the long term. Given the difficulty in performing randomized and 
controlled clinical trials (RCTs) that simultaneously compare several psychotherapeutic models, meta-analyses aim to provide answers 
by synthesizing the evidence generated through direct comparisons of treatments. 
Goals: This protocol describes the meta-analysis study we will perform in order to assess the efficacy and acceptability of long-term 
results of psychotherapy (i.e., 18-month follow-up or higher) in the treatment of major depression in adults. 
Methods: Through the use of a recent methodological approach - the network meta-analysis - we will integrate the direct and indirect 
analysis of evidence from randomized and controlled clinical trials in this domain. We will systematically search seven databases for 
RCTs of psychotherapy, published since 1994, with evaluation of the efficacy in terms of long-term results for the treatment of 
depression. All studies with adult participants (18 to 65 years of age) diagnosed with major depression (according to DSM-IV, IV-TR, V 
or ICD-9, 10) will be eligible and all studies that compare psychotherapy (individual and face-to-face treatment) with a control condition 
(waiting-list, placebo) will be considered. Data extraction, quality assessment and risk of bias will be carried out independently by three 
researchers. The primary outcome measure will be the long-term efficacy of treatments (follow-ups of 18 months or above) measured 
by changes in the overall clinical response and symptoms of depression since post-treatment and follow-ups. The secondary measure 
will be the acceptability of treatment as measured by the proportion of participants who drop out of follow-up or start another 
treatment (not psychotherapy). A direct comparison (pairwise meta-analysis) of all studies comparing different psychotherapies will 
be performed. We will compare relative efficacy and acceptability by indirect comparison, through a bayesian network meta-analysis 
of random effects to compare different psychological interventions. Further analyses will be conducted if inconsistency and 
heterogeneity values are found.  
Discussion: The purpose of this review is to systematize and integrate evidence of long-term maintenance of the results of different 
psychotherapeutic treatments for major depression, administered individually and face-to-face in RCTs. For this reason, multiple direct 
and indirect comparisons of treatments (bayesian network) will be made, and the interrelationships between treatments will be 
estimated in terms of long-term efficacy and acceptability. Even though our scope will be focused on RCTs, we hope that the results 
obtained can contribute to summarize the present evidence available in terms of long-term results of psychotherapy (i.e., its 
effectiveness), optimizing the planning of future studies, providing public health guidelines and more informed clinical decisions on 
the treatment of depression.  
 
















Depression is currently considered a serious public 
health problem. It is the most frequent mental 
disorder, with a high relapse rate. About 50% of 
individuals relapse two years after the first occurrence 
of a major episode of depression (Emmelkamp, 2013; 
Vittengl, Clark, & Jarrett, 2009) and has a worse 
prognosis after each episode. According to Kessler, 
Petukhova, Sampson, Zaslavsky and Wittchen (2012), 
it is estimated that one in every 10 people, in the 
international scenario, suffers from major depression, 
pointing to a prevalence of 16.6%. Authors also 
estimate that 29.9% of healthy people so far will 
develop a major depression episode over the course 
of their life cycle (lifetime morbid risk – Kessler et al., 
2005). With a global estimate of 350 million people 
directly affected worldwide (Marcus, Yasamy, 
Ommeren, Chisholm, & Saxena, 2012), depression is 
considered by the World Health Organization (WHO) 
as the world's fourth leading cause of disability and is 
expected to become the second leading cause of 
disability worldwide by 2020 and the first by 2030 
(Christodoulou, 2012). For this reason, depression 
remains a challenging area of research of great 
concern and relevance, and the inquiry towards which 
are the most efficacious psychological treatments is 
still open, particularly with regard to the long-term 
evolution of this disorder. The lifetime morbid risk, 
high rates of recurrence and relapse throughout life 
are highlighted as major concerns regarding this 
disorder and seen as hallmarks of its long-term course 
(Vittengl, Clark, & Jarrett, 2009, 2010). 
 
The efficacy of psychotherapy in the treatment of mild 
to moderate depression has been well documented 
and supported through several randomized clinical 
trials (RCTs) and previous meta-analyses (see Barth et 
al., 2013; Cuijpers et al., 2013a; Cuijpers, van Straten, 
Warmerdam, & Andersson, 2008; Driessen et al., 
2010). According to these studies, different 
psychological treatments are considered efficacious in 
the short-term treatment of depression, such as 
cognitive behavioral therapy (CBT) (Cristea et al., 
2015; Cuijpers et al., 2013a; Cuijpers et al., 2013b; 
Tolin, 2010), brief psychodynamic therapy (Driessen et 
al., 2015; Leichsenring & Rabung, 2011), interpersonal 
therapy (Barth et al., 2013; Weissman et al., 2014), 
problem-solving therapy (Cape, Whittington, 
Buszewicz, Wallace, & Underwood, 2010; Nieuwsma 
et al., 2012), mainly achieving equivalent results 
(classically known as the Dodo Bird Verdict – cf. 
Luborsky et al., 2002). 
 
If there is a priori solid evidence and vast empirical 
support for the efficacy and equivalence of 
psychotherapies in the treatment of depression and 
its short-term outcomes (by comparing different 
psychotherapeutic approaches in the post-treatment 
and during the first months after therapy 
termination), the evidence regarding the maintenance 
of long-term outcomes is not yet clear (especially 
when considering therapeutic gains at a time distance 
superior than one year after the end of treatment). In 
fact, meta-analytical research that focuses on the 
comparison of the results of different 
psychotherapeutic modalities reveals inconsistencies 
regarding the most efficacious psychotherapeutic 
approach(es), taking into account the maintenance of 
gains in follow-up evaluations (FUP).  
 
Focusing on CBT as an example, some meta-analyses 
(e.g. Tolin, 2010) indicate the superiority of this type 
of treatment (relative to others) in a short-term 
assessment of the evolution of depression (mean FUP 
of 6 months), while others find no differences in FUP 
between CBT and other treatments (e.g. Braun, 
Gregor & Tran, 2013; Driessen et al., 2015). Taking as 
an example the meta-analysis of Tolin (2010), this 
author concluded that CBT was more efficacious in 
FUPs when compared with other forms of 
psychotherapy. Marcus, Yasamy, Ommeren, Chisholm 
and Saxena (2014) also corroborated this result in 
favor of CBT, although only at the 6-month FUP. In 
contrast, in the study by Braun et al. (2013), when 
comparing FUP between one and 24 months (between 
psychodynamic therapy and interpersonal therapy), 
and in the study by Driessen et al. (2015), of short-
term psychodynamic psychotherapy comparing other 
psychotherapies, including CBT, with FUP time points 
of four, eight and 33 weeks, no differences were found 
supporting superiority of CBT in short- and long-term.  










This inconsistency of results has led some authors to 
point out criticisms to these previous meta-analyses 
and to highlight the need to adopt more appropriate 
methodological procedures. For example, Wampold 
et al. (2017) refer to the need of conducting additional 
tests that support the correct rejection or acceptance 
of the null hypothesis (i.e. that there are no 
differences between treatments) and to become more 
explicit regarding standardized treatments under 
comparison (i.e., there is some ambiguity between 
studies with regard to the definition, classification and 
characterization of CBT treatments being 
implemented given that they seem to be 
heterogeneous among studies). Wampold et al. (2017) 
also stress the need to mitigate methodological biases 
in the design of studies, given their possible impact on 
the conclusions that are drawn, particularly with 
regard to the comparative efficacy of treatments (see 
Comer & Kendall, 2013; Wampold et al, 2017, for a 
more complete critical reflection). 
 
The long-term efficacy of psychotherapy in 
depression: why is this review important? 
 
According to the evidence and criticisms pointed out 
to previous meta-analyses, this study aims to 
contribute for the answer to this crucial clinical 
question: What (or which) is the most effective and 
acceptable psychotherapeutic model to maintain 
long-term results (i.e., over 18 months) in the 
treatment of major depression? Answering this 
question would allow us to make more informed and 
substantiated clinical decisions at the level of public 
health guidelines and act with greater safety in the 
treatment of depression. 
 
To this end, we will use a new meta-analytical 
approach, known as network meta-analysis, which 
integrates direct comparisons (primary study results, 
RCTs) with indirect comparisons of multiple 
treatments. In the absence of RCTs studies that 
directly compare all treatments of interest, this new 
approach will allow us to analyze whether treatment 
B is more efficacious than A, and how much treatment 
C is better than the same comparator A, (e.g., 
psychotherapeutic treatment Y or psychotherapeutic 
treatment X).  
 
 
Thus, this article aims to outline the steps of a 
systematic literature review protocol and its empirical 
evaluation, through the methodology of network 
meta-analysis in order to systematize and synthetize 
the evidence from different studies carried out in this 
area and to compare the efficacy and acceptability of 
different psychotherapeutic treatments. Acceptability 
is defined here by the proportion of participants who 
abandon follow-up or initiate another type of 
treatment (see Kazdin, 1981, for a broader 
understanding of the construct of treatment 
acceptability). We are interested in comparing the 
efficacy of “pure” psychotherapies (i.e., 
psychotherapy treatments without combination with 
pharmacology or other non-psychotherapeutic 
interventions) in the maintenance of long-term results 
(FUP of 18 months or more) for the treatment of major 
depression in adults.  
 
In addition to the innovative potential of this 
systematic review and meta-analysis due to the 
adoption of statistical procedures that are currently 
more recommended, up until now there are no meta-
analytical studies whose primary objective is to 
systematize and compare the long-term effects of 
psychotherapy treatments for major depression in 
adults (using moderator analyses in relation to 
treatment FUP time and considering FUP times equal 
to or superior than 18 months). Thus, the results of 
this meta-analysis will contribute to a better 
grounding of decisions regarding the treatment and 
management of the course and long-term evolution of 
depression, with the aim of ultimately reducing its 
negative impact at individual, societal and economic 
levels (Christodoulou, 2012; Kessler et al., 2012; 





This systematic review of the literature and network 
meta-analysis will be conducted in accordance with 
Cochrane's recommendations (guidelines), as outlined 
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in the Handbook for Systematic Reviews of 
Interventions (Higgins, & Green, 2011). Results will be 
reported following the verification items of the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA-NMA – Moher et al, 2015). 
 
Eligibility criteria for studies in this review 
 
Type of studies 
 
Inclusion criteria: We will include in this network 
meta-analysis, randomized controlled clinical trials 
(RCTs) of psychotherapeutic treatments for major 
depression with evaluation of therapeutic efficacy in 
the maintenance of long-term results (FUP ≥ 18 
months), using the Beck Depression Inventory (BDI) or 
other similar standardized measures to evaluate the 
results at the level of symptomatology of depression. 
All RCTs with a control condition (e.g., waiting list or 
placebo) or other psychotherapeutic treatment will be 
included. We will also include relevant follow-up 
studies (prospective) provided that participants derive 
from controlled RCTs, with detailed reporting of the 
results of the primary study (RCT) in which those 
participants were involved.  
 
Exclusion criteria: We will exclude clinical trials of 
treatment efficacy for major depression (such as, for 
example, routine practice studies), non-randomized 
and uncontrolled trials, cross-sectional studies or case 
series. 
 
Type of participants 
 
Inclusion criteria: All studies with adult participants 
between 18 and 65 years of age who meet the criteria 
for diagnosis of major depression will be eligible. 
Diagnostic criteria should be in accordance with the 
Diagnostic Manual of Mental Disorders (DSM-IV, IV-
TR, V; American Psychiatric Association (APA), 1994, 
2000, 2013) or International Classification of Diseases 
and Health Related Problems (ICD-9 – World Health 
Organization, 1978 or ICD-10 – World Health 
Organization, 1992) for major depression. In order to 
reduce clinical heterogeneity, this meta-analysis will 
only include studies whose participants have been 
evaluated by self-reporting instruments of depression, 
namely, the Beck Depression Inventory (BDI), or other 
similar standardized measures to evaluate outcome at 
the level of symptomatology of depression 
(standardized instruments measure). 
Exclusion criteria: In demographic terms, studies with 
children, adolescents and the senior population over 
65 years of age will be excluded. In clinical terms, 
studies with participants who come from specific 
populations, such as patients with chronic diseases 
(e.g. myocardial infarction, multiple sclerosis, stroke, 
cancer, arterial disease, etc.) or with major depression 
related to pregnancy, childbirth or puerperium (e.g. 
postpartum major depression) will be excluded. 
Studies involving participants with comorbidity of 
psychiatric disorders related to substance use or 
addiction will also be excluded.  
 
We assume that any participant who meets the 
inclusion criteria is equally likely to be randomized for 
any of the eligible interventions. 
 
Type of interventions 
 
We will include RCT studies that directly compare the 
efficacy of long-term psychotherapy with a control 
condition (waiting list or placebo) and another 
psychotherapeutic intervention, administered in 
individual and face-to-face formats. We will include 
clinical trials with different dose (dose-effect) of 
treatment, in particular, the number of sessions 
involved in the initial RCT treatment (i.e. whether 12 
sessions is better or worse than 16 sessions, with 
respect to the maintenance of post-treatment results 
over the course of FUP times). Interventions will be 
stratified according to the treatment and dose of 
treatment to detect inequalities that may affect 
comparative efficacy. Due to the fact that different 
psychotherapies have different therapeutic 
approaches and differ in dose (Zhou et al., 2019; 
Cuijpers, Huibers, Ebert, Koole, & Andersson, 2013), 
we will classify level of dose in: low (six sessions or 
less); medium (six to 12 sessions) and high (12 sessions 
or more). Based on the expert authors (e.g. Barth et 
al, 2013; Cuijpers et al, 2008) and the guidelines of the 
Society of Clinical Psychology, interventions will be 
included as follows: Cognitive-behavior therapy, 
Behavior Therapy/Behavioral Activation, Cognitive 
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Therapy, Cognitive Behavioral Analysis System of 
Psychotherapy, Interpersonal Therapy, Problem-
Solving Therapy, Self-Management/Self-Control 
Therapy, Acceptance and Commitment Therapy, 
Emotion-Focused Therapy, Rational Emotive 
Behavioral Therapy, Reminiscence/Life Review 
Therapy, Self-System Therapy, Short-Term 
Psychodynamic Therapy. All other forms of 
administration of psychotherapeutic treatments will 
be excluded (e.g., group intervention, using the 
telephone or internet, such as blended treatments). In 
addition, psychotherapeutic treatments combined 
with pharmacotherapy or other forms of non-
psychological treatments will also be excluded. In 
order to reduce outcome bias, studies with a “usual 
care” or “treatment as usual” control group will also 
be excluded, since this intervention may have 
combined treatments (Barth et al, 2013), including a 
psychological intervention. If another type of 
psychological intervention not listed here is identified, 
its comparability will be assessed based on the 
assumptions defined a priori and, if considered 
eligible, it will be included in the network analysis. 
Studies with follow-up inferior to 18 months after the 
end of treatment will be excluded. 
 
Type of outcome measures 
 
Primary outcome (follow-up measures). The outcome 
measures obtained in the post-treatment period will 
be compared with the outcome measures related to 
long-term FUP results (considering FUP at multiple 
moments and final FUP, equal to or superior than 18 
months) (Shinohara et al., 2013; Zhou et al., 2015). 
Studies whose participants initiated another type of 
treatment in the follow-up period (pharmacotherapy 
or other psychological treatment/psychotherapy) will 
be excluded.  
 
Overall efficacy. We will obtain the primary results 
based on the changes (scores) obtained in depression 
inventories (e.g., BDI; Beck, Steer, & Garbin, 1988), 
adopting the cut-off points defined by the authors 
(standardized instruments measuring). Two analytical 
approaches will be used for evaluating efficacy: 
 
1. Comparing the efficacy of treatments in maintaining 
long-term results, from post-treatment, across follow-
ups (time points) and end of follow-up. The efficacy of 
long-term outcomes in the different 
psychotherapeutic interventions will be defined here 
as the general change in the mean of the depression 
severity scales.  
 
2. Comparing the efficacy of treatments in maintaining 
long-term results, measured by the follow-up time in 
which it remained stable (without relapse).     
 Acceptability. We will compare the acceptability of 
different interventions, defined by the proportion of 
participants who dropout the follow-up for any reason 
(namely, because they start another type of 
treatment: psychotherapeutic treatment, 
pharmacology).  
 
Secondary outcomes. In all eligible studies, and where 
available, we will analyze the perception of 
improvement (in general), quality of life, improved 
functioning, and/or overall well-being measure. 
 
Search methods for identification of studies 
 
The systematic literature search strategy will involve 
electronic databases (through pre-defined key words) 
and manual literature search. In addition, a literature 
review will be carried out specifically for unpublished 
studies that are already in the process of 
preparing/submitting publications. For this purpose, 
direct contact with researchers in psychotherapy will 
be initiated through an e-mail that will be sent to the 
mailing list of members of a research society in 
psychotherapy (i.e. Society of Psychotherapy 
Research – SPR). 
 
The references listed in the articles accepted for full 
reading will also be consulted and used (this strategy 
will allow us to find other studies that have not been 
accessed by the previous research).   
 
For the electronic search, and to “guarantee adequate 
and efficient coverage” (Bramer, Rethlefsen, Kleijnen, 
& Franco, 2017) for our topic of interest, we will select 
the following seven databases: Academic Search 
Complete, ERIC, PsycARTICLES, PsycINFO, Medline, B-
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on, and NCBI Resources (PubMed). The keywords used 
in the search will be: Major depression, Randomized 
control trial, Psychotherapy, Follow up, used in 
different combinations with the terms ((major 
depression) OR (major depressive) OR (depression)) 
AND ((random* control* trial*) OR (random* trial*) 
OR (random* clinical trial*)) AND ((therap*) OR 
(psychotherap*) OR (psychological treatment*) OR 
(counsel*)) AND ((follow up) OR (followup) OR (follow-
up) OR (long term) OR (longterm) OR (relapse) OR 
(maintenance) OR (maintenance "of" gains). In order 
to ensure that the included studies are of an 
acceptable quality, only literature published (or 
submitted for publication) in peer-reviewed scientific 
journals will be included; dissertations and books will 
be excluded from the review. Taking into account the 
innovative nature of this meta-analysis (focusing 
exclusively on long-term results, with follow-ups of 18 
months or more), and to ensure that as many articles 
are retrieved as possible, we will consider the DSM-IV, 
DSM-IV TR and DSM-V versions (APA, 1994, 2000, 
2013) of the diagnostic criteria for major depression. 
Literature published from 1994 to December 2016 will 
be eligible for consideration. 
 
Studies that meet the quality and eligibility criteria 
described above but are not included in the databases 
because they have not yet been published will involve 
direct contact with researchers in psychotherapy, 
established through an email explaining the objectives 
and scope of this study which will be sent to the 
mailing list of members of psychotherapy research 





Selection of studies. The analysis and selection of the 
studies, at all stages, will meet the defined eligibility 
criteria. The group will consist of five researchers 
(authors and three more researchers to be recruited). 
One researcher (first author) will do the bibliographic 
research. Two researchers (first author and another 
judge) will independently analyze titles and abstracts. 
Secondly, a team of four researchers (first author and 
three judges) will analyze the full texts and determine 
the inclusion and eligibility of the studies. The inter-
judges agreement will be assessed using the Cohen’s 
kappa (Cohen, 1960). In case of disagreement, this will 
be resolved by consensus or arbitration/audit with a 
fifth researcher (second author). 
 
Data extraction and management 
 
Data will be independently extracted by the above-
mentioned researchers. The audit researcher will 
resolve any disagreement. From the studies under 
analysis, the scores of the standardized scales (e.g., 
BDI), population studied, sample size, interventions in 
focus (treatment, dose-response, follow-up time, time 
points), comparators, potential risks of bias, results 
and statistical analysis methods used will be extracted 
into an Excel sheet. 
 
In case of high variability in the follow-up time and the 
time points of the studies under analysis, the 
intermediate measures will be converted into means 
and compared to the means of the last follow-up.  
 
Risk assessment of bias. The Cochrane's data 
extraction form 'Risk of bias' tool (Higgins, 2011) will 
be used to assess the methodological quality and 
determination of the risk of "low risk", "unclear risk" 
and "high risk" bias, according to six domains: 1. 
Random sequence generation; 2. Allocation 
concealment; 3. Blinding the evaluation of results; 4. 
Incomplete results data; 5. Selective reports and 6. 
Other sources of bias. The risk of bias "Concealment of 
participants and therapists, domains of data 
extraction” will not be assessed, since psychological 
treatments are differentiated not only by theoretical 
assumptions, but also by the set of interventional 
techniques imposing mastery of the therapeutic 




Measures of treatment effect 
 
Relative treatment effects. We will extract the relative 
estimates of effects by comparison between pairs of 
treatments (pairwise) of the different 
psychotherapeutic interventions and control 
conditions in the post-treatment and throughout the 
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follow-up. The results with dichotomous outcomes 
(clinical response) will be analyzed by calculation of 
odds ratio (OR) and respective 95% confidence 
intervals. When different measures are used to 
evaluate the same outcome in continuous variables 
(change in severity scales of symptoms of depression, 
change in the scale of functioning, quality of life or 
well-being), these will be grouped by the difference of 
the standardized mean  and respective 95% 
confidence intervals, using Hedges' adjusted g. In 
studies where the means or standard deviation are 
not available, they will be calculated using standard 
errors, 95% confidence intervals and/or p-values 
(Follmann, Elliott, Suh & Cutler, 1992).  
 
Ranking treatments. We will obtain a hierarchy (the 
best treatment, the second best and so on) of the 
competing treatments using the surface under the 
cumulative ranking curve (SUCRA) and odds ratio (OR). 
We will also estimate the probability of each 
treatment being ranked first by the percentage 
efficacy and acceptability, according to the surface 
under the cumulative classification curve (SUCRA) as 





First, we will conduct a meta-analysis (pairwise, direct 
comparison) with a random effects model using 
Review Manager (V.5.2). Second, we will conduct a 
Bayesian network random effects meta-analysis 
(indirect comparison), allowing the estimation of the 
effects of all psychotherapies (intervention vs. 
control) in the post-treatment and follow-ups analysis 
by combining direct and indirect evidence. We will 
perform the network meta-analysis using the 
WinBUGS version 1.4.3 (MRC Biostatistics Unit 2007) 
and we will estimate the parameters based on 100 000 
interactions by the Markov chain Monte Carlo 
methods (MCMC; Barth, 2013, Zhou, 2015). From the 
results of the network meta-analysis, a summary of 
the relative effect sizes (standardized mean difference 
or odds ratio) will be presented. We will evaluate the 
presence of heterogeneity in each pairwise 
comparison using the I² squared statistic and 95% 
confidence interval. The evaluation of statistical 
heterogeneity throughout the network will be based 
on the magnitude of the parameter of variance 
between studies (τ²) (Turner, Davey, Clarke, 
Thompson, & Higgins, 2012). We will compare the 
distribution of comparator effects (e.g., 
psychotherapeutic treatment vs. psychotherapeutic 
treatment or waiting list or placebo) from the studies 
in the different pairwise comparisons to assess 
assumption of transitivity. Inconsistency will be 
evaluated between direct estimates (all intra-study 
comparisons) and indirect estimates (e.g., 
psychotherapies, treatment time, dose response, type 
of analysis, outcome assessment and study sample 
size) (Higgins, Jackson, Barrett, Lu, Ades, & White, 
2012; White, Barrett, Jackson & Higgins, 2012). The 
presence of inconsistency will be inferred by the 
magnitude of the inconsistency factors and 95% 
confidence interval for each loop (Song, Altman, 
Glenny, & Deeks, 2003). The forest plot chart will 





We will carry out, whenever possible, analyzes by sex 
of the participants (men or women), age of the 





In the presence of high inconsistency values or high 
heterogeneity, we will perform a meta-regression or 
subgroup analysis (precision of the study, results in 
terms of severity of symptoms of depression in the 
post-treatment, studies with a high bias) to analyze 
the estimated effect size. If there is a significant 
change estimated effect size, studies related to the 
increase of the variance effect size will be removed 
from further analysis. 
 
 
Ethics and dissemination 
 
A systematic review and network meta-analysis will be 
subsequently submitted for publication in peer-
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reviewed journal. Since the study that will be 
performed is based on data already collected by the 
authors of the primary studies and the consent of the 
participants was already obtained, we will not need a 
new formal submission to the ethics committee. 
This systematic review/meta-analysis protocol was 
registered in the International prospective register of 
systematic reviews (Vieira & Cunha, 2017) with 






Our review will analyze the efficacy of psychotherapy 
for treating major depression through multiple direct 
and indirect comparisons of evidence regarding 
different psychotherapeutic treatments tested in 
randomized controlled clinical trials (RCTs), taking into 
account the maintenance of gains evidenced in follow-
up evaluations (FUPs) equal to and greater than 18 
months, after the completion of treatments for major 
depression in adults. We will prioritize the treatments 
administered individually and face-to-face, given that 
the largest volume of reviews focuses on the results of 
interventions in blended treatments (mixed formats), 
such as comparing the results of different treatments 
administered in group versus individual formats (Tolin, 
2010), group versus individual versus face-to-face 
versus self-help formats (Cuijpers et al., 2013a), 
psychotherapeutic versus pharmacological 
treatments (Cuijpers et al., 2013b), or treatments for 
different diagnoses (Marcus et al., 2014; Tolin, 2010).  
 
We aspire to be able to provide insights for the 
protocol definition of future RCTs, specifically with 
regards to the designs of clinical research, based on 
the analysis of the evidence provided by previous 
trials (Salanti et al., 2018), as well as to support the 
definition of clearer and more informed public health 
guidelines that may help to make adequate clinical 
decisions for the treatment of major depression, 
supported by more sustained evidence. Although our 
review does not analyze the mechanisms of 
therapeutic change, or as Wampold et al. (2017) puts 
it, "What makes psychotherapy work?", we consider 
that an innovative and relevant aspect of this work is 
to address the long-term effectiveness of currently 
evidence-based and empirically supported treatments 
(according to the understanding of entities such as the 
Society of Clinical Psychology – division 12 of the APA, 
2016). 
Furthermore, considering that the rates of relapse of 
depression are high (50% after two years of the first 
occurrence; Vittengl, Clark, & Jarrett, 2009), it is 
essential to grasp which are psychotherapeutic 
treatments that may be more promising in the long-
term. This study aims to contribute for the answer to 
this essential question, with relevant implications for 
the definition of public health guidelines that can 
prevent the recurrence of major depression and 
minimize the socioeconomic impact of this disorder. 
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